Gene · 338413
Papers2,372
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,021 to 1,040 of 2,372
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Oleuropein, a Bioactive Compound from Olea europaea L., as a Potential Preventive and Therapeutic Agent in Non-Communicable Diseases. | Antioxidants (Basel) | 2019 | 31766676 | PubTator, text mining | PubMed |
| Skills in computational thinking of engineering students of the first school year. | Heliyon | 2019 | 31763478 | PubTator, text mining | PubMed |
| Treatment with a Combination of Metformin and 2-Deoxyglucose Upregulates Thrombospondin-1 in Microvascular Endothelial Cells: Implications in Anti-Angiogenic Cancer Therapy. | Cancers (Basel) | 2019 | 31698699 | PubTator, text mining | PubMed |
| mTOR and autophagy pathways are dysregulated in murine and human models of Schaaf-Yang syndrome. | Sci Rep | 2019 | 31685878 | PubTator, text mining | PubMed |
| A multi-modal data resource for investigating topographic heterogeneity in patient-derived xenograft tumors. | Sci Data | 2019 | 31672976 | PubTator, text mining | PubMed |
| An integrative pharmacogenomics analysis identifies therapeutic targets in KRAS-mutant lung cancer. | EBioMedicine | 2019 | 31668570 | PubTator, text mining | PubMed |
| Dysregulation of Mitochondrial Ca2+ Uptake and Sarcolemma Repair Underlie Muscle Weakness and Wasting in Patients and Mice Lacking MICU1. | Cell Rep | 2019 | 31665639 | PubTator, text mining | PubMed |
| Role of mTOR Signaling in Female Reproduction. | Front Endocrinol (Lausanne) | 2019 | 31649622 | PubTator, text mining | PubMed |
| Induction of metabolic quiescence defines the transitional to follicular B cell switch. | Sci Signal | 2019 | 31641080 | PubTator, text mining | PubMed |
| MIBI-TOF: A multiplexed imaging platform relates cellular phenotypes and tissue structure. | Sci Adv | 2019 | 31633026 | PubTator, text mining | PubMed |
| A kinase-independent role for CDK8 in BCR-ABL1+ leukemia. | Nat Commun | 2019 | 31628323 | PubTator, text mining | PubMed |
| Maternal energy insufficiency affects testicular development of the offspring in a swine model. | Sci Rep | 2019 | 31601864 | PubTator, text mining | PubMed |
| Adenosine mediates functional and metabolic suppression of peripheral and tumor-infiltrating CD8+ T cells. | J Immunother Cancer | 2019 | 31601268 | PubTator, text mining | PubMed |
| Noninvasive Bimodal Neuromodulation for the Treatment of Tinnitus: Protocol for a Second Large-Scale Double-Blind Randomized Clinical Trial to Optimize Stimulation Parameters. | JMIR Res Protoc | 2019 | 31573942 | PubTator, text mining | PubMed |
| Addressing Patient Specificity in the Engineering of Tumor Models. | Front Bioeng Biotechnol | 2019 | 31572718 | PubTator, text mining | PubMed |
| Inhibition of esophageal cancer growth through the suppression of PI3K/AKT/mTOR signaling pathway. | Onco Targets Ther | 2019 | 31571914 | PubTator, text mining | PubMed |
| Germline NPM1 mutations lead to altered rRNA 2'-O-methylation and cause dyskeratosis congenita. | Nat Genet | 2019 | 31570891 | PubTator, text mining | PubMed |
| Breast Tissue Biology Expands the Possibilities for Prevention of Age-Related Breast Cancers. | Front Cell Dev Biol | 2019 | 31555644 | PubTator, text mining | PubMed |
| Molecular Dynamics Study of the Hybridization between RNA and Modified Oligonucleotides. | J Chem Theory Comput | 2019 | 31553600 | PubTator, text mining | PubMed |
| PIK3CA and MAP3K1 alterations imply luminal A status and are associated with clinical benefit from pan-PI3K inhibitor buparlisib and letrozole in ER+ metastatic breast cancer. | NPJ Breast Cancer | 2019 | 31552290 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/338413/papers?page=52